TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 5.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $335 | -64.2% | 40,104 | +6.3% | 0.00% | -66.7% |
Q2 2023 | $937 | +46.4% | 37,720 | -11.3% | 0.01% | +50.0% |
Q1 2023 | $640 | +30.1% | 42,535 | +2.2% | 0.00% | 0.0% |
Q4 2022 | $492 | -99.8% | 41,624 | -7.4% | 0.00% | +100.0% |
Q3 2022 | $266,000 | +220.5% | 44,928 | +130.1% | 0.00% | +100.0% |
Q2 2022 | $83,000 | -65.4% | 19,525 | -22.6% | 0.00% | 0.0% |
Q1 2022 | $240,000 | -45.2% | 25,238 | +9.4% | 0.00% | -50.0% |
Q4 2021 | $438,000 | -30.3% | 23,077 | +22.3% | 0.00% | -33.3% |
Q3 2021 | $628,000 | +19.8% | 18,874 | +39.7% | 0.00% | 0.0% |
Q2 2021 | $524,000 | -5.1% | 13,507 | +18.0% | 0.00% | 0.0% |
Q1 2021 | $552,000 | +14.3% | 11,447 | +23.3% | 0.00% | 0.0% |
Q4 2020 | $483,000 | +219.9% | 9,281 | -19.0% | 0.00% | +200.0% |
Q2 2018 | $151,000 | -14.7% | 11,456 | -8.0% | 0.00% | 0.0% |
Q1 2018 | $177,000 | +17.2% | 12,455 | -32.4% | 0.00% | 0.0% |
Q4 2017 | $151,000 | +319.4% | 18,417 | +210.1% | 0.00% | – |
Q2 2016 | $36,000 | -5.3% | 5,939 | +31.9% | 0.00% | – |
Q1 2016 | $38,000 | -7.3% | 4,503 | +32.2% | 0.00% | – |
Q4 2015 | $41,000 | -6.8% | 3,405 | -21.6% | 0.00% | – |
Q3 2015 | $44,000 | +120.0% | 4,342 | +262.4% | 0.00% | – |
Q2 2015 | $20,000 | +42.9% | 1,198 | +28.4% | 0.00% | – |
Q1 2015 | $14,000 | 0.0% | 933 | +7.7% | 0.00% | – |
Q4 2014 | $14,000 | – | 866 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |